Combined Flush With Histidine-Tryptophan-Ketoglutarate and University of Wisconsin Solutions in Liver Transplantation: Preliminary Results

Ischemia reperfusion injury (IRI) is the main cause of early allograft dysfunction (EAD) and subsequent primary allograft failure (PAF). The purpose of this study is to compare IRI, EAD, and PAF in liver transplantation in a cohort of patients perfused with histidine-tryptophan-ketoglutarate (HTK) s...

Full description

Saved in:
Bibliographic Details
Published in:Transplantation proceedings 2018-03, Vol.50 (2), p.539-542
Main Authors: León Díaz, F.J., Fernández Aguilar, J.L., Nicolás de Cabo, S., Pérez Reyes, M., Sánchez Pérez, B., Montiel Casado, C., Pérez Daga, J.A., Aranda Narváez, J.M., Suárez Muñoz, M.A., Arenas González, F., Florez Rías, M.M., Pelaez Angulo, J.L., Santoyo Santoyo, J.
Format: Article
Language:English
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Ischemia reperfusion injury (IRI) is the main cause of early allograft dysfunction (EAD) and subsequent primary allograft failure (PAF). The purpose of this study is to compare IRI, EAD, and PAF in liver transplantation in a cohort of patients perfused with histidine-tryptophan-ketoglutarate (HTK) solution and University of Wisconsin (UW) solution versus HTK alone. A randomized trial was performed to compare outcomes in liver recipients who underwent transplantation surgery in the University Regional Hospital of Malaga, Spain. Forty patients were randomized to two groups. Primary endpoints included IRI, EAD, PAF, re-intervention, acute cellular rejection, retransplantation, arterial complications, and biliary complications at postoperative day 90. Postoperative glutamic oxaloacetic transaminase (1869.15 ± 1559.75 UI/L vs. 953.15 ± 777.27 UI/L; P = .004) and glutamic pyruvic transaminase (1333.60 ± 1115.49 U/L vs. 721.70 ± 725.02 U/L; P = .023) were significantly higher in patients perfused with HTK alone. A clear tendency was observed in recipients perfused with HTK alone to present moderate to severe IRI (7 patients in the HTK + UW solution group vs. 15 patients in the HTK-alone solution group; P = .06), EAD (0 patients in the HTK + UW solution group vs. 0 patients in the HTK-alone solution group; P = .76), and PAF (3 patients in the HTK + UW solution group vs. 8 patients in the HTK-alone solution group; P = .15). Initial perfusion with HTK solution followed by UW solution in liver transplantation improves early liver function as compared to perfusion with HTK alone. •Combined perfusion with histidine-tryptophan-ketoglutarate solution (HTK) followed by University of Wisconsin (UW) solution in liver transplantation has been proven safe.•Combined perfusion with HTK followed by UW solution in liver transplantation reduces ischemia reperfusion injury as compared to perfusion with HTK alone.•Combined perfusion with HTK followed by UW solution in liver transplantation improves early liver function as compared to perfusion with HTK alone.
ISSN:0041-1345
1873-2623
DOI:10.1016/j.transproceed.2017.12.033